Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration authorized the emergency use of the mRNA vaccine, BNT162b2, against Covid-19 in individuals 16 years of age or older.
FDA Advisory Committee Gives Green Light to Pfizer-BioNTech Covid-19 Vaccine"Operation Warp Speed" Initiative, Advisory Committees, Airlines, Allergic Reactions, BioNTech, Clinical Trials, COVID-19 Vaccines, Efficacy Data, Emergency Use Authorization, FDA, Federal Aviation Administration (FAA), Messenger RNA (mRNA) Vaccines, Pfizer, R&D, The Wall Street Journal, United Kingdom
The U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee voted 17-4 to recommend Pfizer and BioNTech’s Covid-19 vaccine for Emergency Use Authorization (EUA) for individuals ages 16 years and older.
AstraZeneca U.S. Covid-19 vaccine trial results likely in late January 2021"Operation Warp Speed" Initiative, AstraZeneca, Brazil, Clinical Studies, Clinical Trials, COVID-19 Vaccines, Data, Department of Health and Human Services (HHS), Efficacy Data, Emergency Use Authorization, Health Officials, Oxford University, R&D, Scientists, U.S. government, United Kingdom
AstraZeneca Plc will likely get results of the company’s U.S. Covid-19 vaccine trial in late January 2021 and could potentially file for an emergency authorization, the chief adviser for the U.S. government’s Operation Warp Speed program said.
Healthcare workers and others recommended for the first Covid-19 inoculations could start getting shots within 24 hours after the vaccine receives regulatory authorization, the chief adviser for the U.S. government’s Operation Warp Speed program said.
Airlines Gear Up to Fly Covid-19 Vaccines to U.S. Distribution Sites"Operation Warp Speed" Initiative, Advisory Committees, Airlines, Belgium, BioNTech, Business, COVID-19 Vaccines, Distribution, Emergency Use Authorization, FDA, Federal Aviation Administration (FAA), Michigan, Pfizer, U.S. Department of Transportation (USDOT)
With both Pfizer-BioNTech and Moderna’s Covid-19 vaccines at the U.S. Food and Drug Administration awaiting potential Emergency Use Authorization (EUA), airlines are preparing their cargo operations to ship the vaccines.
Americans defy pandemic, political leaders to travel for Thanksgiving"Operation Warp Speed" Initiative, Airports, Andrew Cuomo (NY), Coronavirus Disease (COVID-19) Pandemic, Coronavirus Infections, COVID-19 Deaths, COVID-19 Vaccines, Donald Trump, Dr. Anthony Fauci (Director), Joe Biden, Moderna, New York City, Northwestern University, Thanksgiving, Travelers, United States
Americans defied pleas from state and local officials to stay home for the Thanksgiving holiday in the face of the surging coronavirus pandemic, triggering fresh warnings from health officials with the release of vaccines still weeks away.
Americans in holiday rush despite highest Covid-19 death toll in 6 months"Operation Warp Speed" Initiative, Airports, C-SPAN, Christmas, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Deaths, Death Tolls, Dr. Anthony Fauci (Director), FDA, Hospitalized COVID-19 Patients, Mortality Data, New York City, Parents, Schools, Thanksgiving, Travelers
Record hospitalizations and a surging death toll failed to keep Americans from traveling a day before the Thanksgiving holiday, raising fears that the unchecked spread under way is a prelude to further contagion at Christmastime.
U.S. officials plan to release 6.4 million Covid-19 vaccine doses nationwide in an initial distribution after the first one is cleared by regulators for emergency use.
Abbott became the first anchor sponsor of the American Diabetes Association’s Health Equity Now platform to address health disparities for people with diabetes.
Pfizer-BioNTech and Moderna’s Vaccines Lead the Covid-19 Race; How Do They Compare?"Operation Warp Speed" Initiative, AstraZeneca, BioNTech, Business, Clinical Trials, Cold chain storage, COVID-19 Vaccines, Efficacy Data, FDA, Interim Data, Messenger RNA (mRNA) Vaccines, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), NPR, Oxford University, Pfizer, R&D, U.S. government, United States
BioSpace takes a look at Moderna at the similarities between the two, and a few differencesPfizer-BioNTech and Moderna Covid-19 vaccines preliminary data readout of its COVID-19 vaccine suggested a 90% efficacy rate, the U.S. and western countries have the promise of two effective and reasonably safe vaccines. There are . Here’s a look.